top of page

Can't Find Ozempic? 5 FDA-Approved Alternatives to Discuss With Your Doctor

Can't Find Ozempic? 5 FDA-Approved Alternatives to Discuss With Your Doctor

A comprehensive guide to FDA-approved alternatives to Ozempic during the ongoing shortage, explaining their mechanisms and providing key questions to discuss with your doctor.

ree

You should read this guide because it offers essential information about FDA-approved options during the current Ozempic shortage. It addresses common concerns and provides clear, actionable information that can help alleviate anxiety and make informed decisions.

Takeaways


  • The Ozempic shortage is creating challenges for many patients.

  • Several FDA-approved GLP-1 agonists can serve as alternatives.

  • Understanding the mechanisms of these drugs is essential.

  • Consulting your doctor is crucial for personalized guidance.

  • Lifestyle changes remain a cornerstone of diabetes and weight management.


Understanding the Ozempic Shortage and Why It Matters


The Ozempic shortage is not just a minor inconvenience; it's a significant issue impacting the health and well-being of many individuals. As a physician, I've seen firsthand the anxiety and frustration it causes.


The increased demand for GLP-1 agonists, driven by both their efficacy in managing type 2 diabetes and their off-label use for weight loss, has outstripped supply. This shortage is expected to continue, making it essential to explore alternative options.


The implications of not having access to these medications can be serious, especially for patients with diabetes. Uncontrolled blood sugar levels can lead to a range of complications, including nerve damage, kidney disease, and cardiovascular problems. Even for those using it off-label, weight gain can quickly reverse their progress.


I have seen patients who have successfully managed their diabetes with Ozempic for years suddenly facing uncertainty and concern due to its unavailability. Understanding alternative options is vital for the continuity of care.


Manufacturers have announced that the Ozempic shortage is expected to persist due to increased demand and supply chain challenges.

FDA-Approved GLP-1 Agonist Alternatives to Ozempic


Fortunately, there are several FDA-approved GLP-1 agonists that can serve as alternatives to Ozempic. Here's an overview of some of the most common options:


  • Wegovy (semaglutide): This is the same active ingredient as Ozempic, but Wegovy is specifically approved for weight loss. It's administered as a weekly injection and can lead to significant weight reduction.

  • Trulicity (dulaglutide): Another weekly injectable GLP-1 agonist approved for type 2 diabetes. It helps lower blood sugar levels and may also result in modest weight loss.

  • Rybelsus (semaglutide): This is an oral formulation of semaglutide, the same active ingredient as Ozempic and Wegovy. It's taken daily and approved for type 2 diabetes management.

  • Mounjaro (tirzepatide): Mounjaro works as a dual GLP-1 and GIP receptor agonist. It can lower blood sugar and has been shown to cause more weight loss than semaglutide in some studies.

  • Victoza (liraglutide): A daily injectable GLP-1 agonist approved for type 2 diabetes. It helps lower blood sugar levels and may also aid in weight management.


I recently had a patient switch from Ozempic to Mounjaro, and she reported even better blood sugar control and additional weight loss. Each medication works slightly differently, so finding the right fit is crucial.


Here's a table comparing several FDA-approved GLP-1 receptor agonists, outlining their key features:

Drug Name(s) 

Active Ingredient

Administration Method

Approved Uses

Common Potential Side Effects

Ozempic, Wegovy

Semaglutide

Once-weekly subcutaneous injection

Type 2 Diabetes (Ozempic), Chronic Weight Management (Wegovy)

Nausea, vomiting, diarrhea, constipation

Rybelsus

Semaglutide

Once-daily oral tablet

Type 2 Diabetes

Nausea, vomiting, diarrhea, constipation

Trulicity

Dulaglutide

Once-weekly subcutaneous injection

Type 2 Diabetes

Nausea, diarrhea, headache, vomiting

Victoza, Saxenda

Liraglutide

Once-daily subcutaneous injection

Type 2 Diabetes, ASCVD risk reduction (Victoza), Chronic Weight Management (Saxenda)

Nausea, diarrhea, vomiting, injection-site reactions

Byetta, Bydureon / Bydureon BCise

Exenatide

Twice-daily injection (Byetta), Once-weekly injection (Bydureon/Bydureon BCise)

Type 2 Diabetes

Nausea, vomiting, diarrhea, injection-site reactions

Adlyxin

Lixisenatide

Once-daily subcutaneous injection

Type 2 Diabetes

Nausea, vomiting, diarrhea, abdominal pain

Mounjaro, Zepbound

Tirzepatide (GIP/GLP-1RA)

Once-weekly subcutaneous injection

Type 2 Diabetes (Mounjaro), Obesity, OSA (Zepbound)

Nausea, diarrhea, vomiting


Understanding the Mechanisms: How These Drugs Work


To make an informed decision, it's important to understand how these medications work. GLP-1 agonists mimic the effects of the natural hormone glucagon-like peptide-1 (GLP-1) in the body.


  • Stimulating Insulin Release: They help lower blood sugar levels by stimulating the pancreas to release insulin when blood sugar is high.

  • Slowing Gastric Emptying: They slow down the rate at which food empties from the stomach, leading to a feeling of fullness and reduced appetite.

  • Suppressing Appetite: They can act on the brain to suppress appetite and reduce food cravings.


These mechanisms contribute to both improved blood sugar control in patients with type 2 diabetes and weight loss in individuals seeking weight management. However, it's essential to understand that these drugs are not a "magic bullet" and should be used in conjunction with lifestyle changes.


A diagram illustrating the GLP-1 pathway in the body and how GLP-1 agonists mimic its effects to lower blood sugar and suppress appetite.
A diagram illustrating the GLP-1 pathway in the body and how GLP-1 agonists mimic its effects to lower blood sugar and suppress appetite.

What to Ask Your Doctor: A Checklist for Consultation


When discussing Ozempic alternatives with your doctor, it's essential to come prepared with the right questions. Here's a checklist to guide your consultation:


  • Is this medication appropriate for my medical history and current health conditions?

  • What are the potential side effects of this medication, and how can they be managed?

  • How does this medication compare to Ozempic in terms of efficacy for blood sugar control or weight loss?

  • What lifestyle changes (diet and exercise) should I make to maximize the benefits of this medication?

  • How often will I need to be monitored while taking this medication?

  • How long is the prescription expected to last, and will I have trouble refilling it?

  • How much will this medication cost, and is there insurance coverage available?

  • Is there a patient assistance program available if I cannot afford this medication?


I always encourage my patients to be active participants in their healthcare. Asking informed questions ensures that you're making the best decision for your individual needs.


The Cornerstone: Lifestyle Changes for Diabetes and Weight Management


While GLP-1 agonists can be powerful tools, they are most effective when combined with lifestyle changes. I stress this point to all my patients.


  • Balanced Diet: Focus on a diet rich in fruits, vegetables, lean proteins, and whole grains. Reduce processed foods, sugary drinks, and excessive fats.

  • Regular Exercise: Aim for at least 150 minutes of moderate-intensity aerobic exercise per week, plus strength training exercises at least twice a week.

  • Stress Management: Practice stress-reduction techniques like meditation, yoga, or spending time in nature.

  • Adequate Sleep: Aim for 7-8 hours of quality sleep each night.


These lifestyle changes not only enhance the effects of GLP-1 agonists but also contribute to overall health and well-being. They are the foundation upon which successful diabetes and weight management are built.


Summary


Navigating the Ozempic shortage can be challenging, but by understanding the available FDA-approved alternatives, their mechanisms of action, and the importance of lifestyle changes, you can make informed decisions about your health. Consulting your doctor and asking the right questions is crucial for finding the best path forward.


Final Thought


The Ozempic shortage underscores the importance of having a proactive approach to your health. By exploring alternatives and prioritizing lifestyle changes, you can continue to manage your diabetes and weight effectively, even in the face of medication shortages.


Frequently Asked Questions


  1. Are compounded versions of semaglutide safe to use?

    Compounded versions of semaglutide are not FDA-approved and may pose risks. The FDA does not review compounded drugs for safety, effectiveness, or quality. Using compounded drugs can expose patients to potentially unsafe ingredients or incorrect dosages.

  2. What should I do if I experience side effects from a GLP-1 agonist?

    If you experience side effects from a GLP-1 agonist, contact your doctor immediately. They can help you manage the side effects or adjust your dosage.

  3. Can I switch between different GLP-1 agonists without any issues?

    Switching between different GLP-1 agonists should be done under the guidance of your doctor. They can help you safely transition between medications.

  4. How long do the effects of GLP-1 agonists last?

    The effects of GLP-1 agonists last as long as you continue taking the medication. When you stop taking the medication, the effects will gradually wear off.

  5. Are GLP-1 agonists safe for long-term use?

    GLP-1 agonists have been studied for long-term use and are generally considered safe. However, it's important to discuss the potential risks and benefits with your doctor.


Sources


  1. U.S. Food and Drug Administration (FDA). (2023, July 2). FDA Drug Shortages.

  2. Centers for Disease Control and Prevention (CDC). (2024, March 1). Managing Diabetes.

  3. Mayo Clinic. (2024, June 15). Diabetes Drugs: What You Need to Know.

  4. American Diabetes Association (ADA). (n.d.). Medications for Type 2 Diabetes.

  5. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). (n.d.). Diabetes Medications.

  6. Novo Nordisk. (n.d.). Ozempic (semaglutide) injection.

  7. Eli Lilly and Company. (n.d.). Mounjaro (tirzepatide) injection.

  8. National Center for Biotechnology Information (NCBI). (n.d.). Glucagon-like Peptide-1 Receptor Agonists.

  9. The Obesity Society. (n.d.). Obesity Treatment Medications.


About Michael Suter, MD

I'm a physician at Biolife Health Center, committed to delivering exceptional patient care and promoting optimal wellness. With 20 years of experience in medicine, I provide personalized attention and expertise. I'm passionate about helping my patients take control of their health while fostering a supportive environment.


ree

bottom of page